Browse > Article
http://dx.doi.org/10.4333/KPS.2006.36.4.263

The Design and Fabrication of μCCA-μGI Device for Toxicity Evaluation of Acetaminophen  

Chang Jung-Yun (Korea food and Drug Administration)
Shuler Michael L. (Cornell University)
Publication Information
Journal of Pharmaceutical Investigation / v.36, no.4, 2006 , pp. 263-269 More about this Journal
Abstract
Deficiencies in the early ADMET(absorption, distribution, metabolism, elimination and toxicity) information on drug candidate extract a significant economic penalty on pharmaceutical firms. Microscale cell culture analogue-microscale gastrointestinal(${\mu}CCA-{\mu}GI$) device using Caco 2, L2 and HEp G2/C3A cells, which mimic metabolic process after absorption occurring in humans was used to investigate the toxicity of the model chemical, acetaminophen(AAP). The toxicity of acetaminophen determined after induction of CYP 1A1/2 in Caco 2 cells was not significant. In a coculture system, although no significant reduction in viability of HEp G2/C3A and L2 cells was found, approximately 5 fold increase in the CYP 1A1/2 activity was observed. These results appear to be related to organ-organ interaction. The oral administration of a drug requires addition of the absorption process through small intestine to the current ${\mu}CCA$ device. Therefore, a perfusion coculture system was employed for the evaluation of the absolution across the small intestine and resulting toxicity in the liver and lung. This system give comprehensive and physiologic information on oral uptake and resulting toxicity as in the body. The current ${\mu}CCA$ device can be used to demonstrate the toxic effect due to organ to organ interaction after oral administration,
Keywords
${\mu}CCA$(Cell culture analogue); Acetaminophen; CYP 1A1/2;
Citations & Related Records
연도 인용수 순위
  • Reference
1 K. Viravaidya and M.L. Shuler, Incorporation of 3T3-L1 cells to mimic bioaccumulation in a microscale cell culture analogue device for toxicity studies, Biotechnol. Prog., 20, 590-597 (2004)   DOI   ScienceOn
2 D.G. Davidson and W.N. Eastham, Acute liver necrosis following overdose of paracetamol, Br. Med. J., 5512, 497-499 (1966)
3 J.R. Mitchell, Acetaminophen toxicity, N. Engl. J. Med., 31, 1601-1602 (1988)
4 J. Liu, Y. Liu, D. Hartley, C.D. Klaassen, S.E. Shehin-Johnson, A. Lucas and S.D. Cohen, Metallothionein-I/II knockout mice are sensitive to acetaminophen-induced hepatotoxicity, J. Pharmacol. Exp. Ther., 289, 580-586 (1999)
5 S.H. Choi, M. Nishikawa, A. Sakoda and Y. Sakai, Feasibility of a simple double-layered coculture system incorporating metabolic processes of the intestine and liver tissue: application to the analysis of benzo[a]pyrene toxicity, Toxicol. in Vitro., 18, 393-402 (2004)   DOI   ScienceOn
6 B. Davies and T. Morris, Physiological parameters in laboratory animals and humans, Pharm. Res., 7, 1093-1095 (1993)
7 R.D. Kanter, M. Monshouwer, A.L. Draaisa, M.H. De Jager, I.A.M. De Graaf, J.H. Proost, D.K.F. Meijer and G.M.M. Groothuis, Prediction of whole-body metabolic clearance of drugs through the combined use of slices from rat liver, lung, kidney, small intestine and colon, Xenobio., 24, 229-241 (2004)
8 P.T. Manyike, E.D. Kharasch, T.F. Kalhorn and J.T. Salttery, Contribution of CYP 2E1 and CYP 3A to acetaminophen reactive metabolite formation, Clin. Pharm & Therapeu., 67, 275-282 (2000)   DOI   ScienceOn
9 S.D. Nelson, Mechanism of the formation and disposition of reactive metabolites that can cause acute liver injury, Drug Met. Res., 27, 147-177 (1995)   DOI
10 T. Prueksaritanout, L.M. Gorham, J.H. Hochman, L.O. Tran and K.P. Vyas, Comparative studies of drug-metabolizing enzymes in dog, monkey, and human small intestines and in Caco-2 cells, Drug Metab. Dispos., 24, 634-642 (1996)
11 J.A. Brent and B.H. Rumack, Role of free radicals in toxic hepatic injury. II Are free radicals the cause of toxin-induced liver injury.? J. Toxicol. Clin. Toxicol., 31, 173-196 (1993)   DOI   ScienceOn
12 S. Rendic and F.J. Dicarlo, Human cytochrome P450 enzymes: A status report summarizing their reactions, substrates, inducers, and inhibitors, Drug Metab. Rev., 29, 413-80 (1997)   DOI
13 A. Sin, K.C. Chin, M.F. Jamil, Y. Kostov, G. Rao and M.L. Shuler, The design and fabrication of three chamber microscale cell culture analogue devices with integrated dissolved oxygen sensors, Biotechnol. Prog., 20, 338-345 (2004)   DOI   ScienceOn
14 J.D Gibson, N.R. Pumford, V.M. Samokyszyn and J.A. Hinson, Mechanism of acetaminophen-induced hepatotoxi-city: covalent binding versus oxidative stress, Chem. Res. Toxicol., 9, 580-585 (1996)   DOI   ScienceOn
15 V. Carriere, J. Chambaz and M. Rousset, Intestinal response to xenobiotics, Toxicol. in Vitro., 15, 373-378 (2001)   DOI   ScienceOn
16 J.M. Gearhart, G.W. Jepson, H.J. Clewell, M.E. Anderson and R.B. Conolly, Physiologically based pharmacokinetic and pharmacodynamic model for the inhibition of acetyl-cholinesterase by disodiumpropylfluorophosphate, Toxicol. Applied Pharm., 106, 295-310 (1990)   DOI   ScienceOn
17 D.W. Rosenberg and T. Leff, Regulation of cytochrome P450 in cultured human colonic cells, Arch. Biochem. Biophy., 300, 186-192 (1993)   DOI   ScienceOn
18 L.M. Sweeny, M.L. Shuler, J.G. Babish and A. Ghanem, A cell culture analogue of rodent physiology: application to naphthalene toxicology, Toxicol in Vitro., 59, 307-316 (1995)
19 T. Ishida, M. Abe, K. Oguri and H. Yamada, Enhancement of acetaminophen cytotoxicity in selenium-binding protein-overexpressed COS-1 Cells, Drug Metab. Pharmacokin, 19, 290-296 (2004)   DOI   ScienceOn